• SENSEX 82,726.64
    539.83 (+0.66%)
  • BANKNIFTY 57,210.45
    454.45 (+0.80%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,330.55 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,489.95(%)
  • One 97
    1,090.00 1,090.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Ola Electric
    43.95 157.53(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Anthem Bioscienc
    765.00 765.00(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Paradeep Phosph.
    205.60 205.60(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • I R F C
    136.90 208.95(%)
  • Monika Alcobev
    289.95 289.95(%)
  • St Bk of India
    825.00 889.00(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shree Ganesh Biotech India Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 41344.0
  • ISIN : INE051N01026
0.82 0 (1.23%)
  • As on 23 Jul 2025 (EOD)
  • Today’s Low

    0.80
  • Today’s High

    0.82
  • Open

    0.81
  • Perv Close

    0.81
  • 52W Low

    0.80
  • 52W High

    1.29

Key Indicators

  • P/E(TTM)

    82.00

  • Mar.Cap (₹Cr.)

    32.69

  • Div & Yield %

    0.00

  • Book Value(₹)

    1.59

  • Debt-Equity Ratio

    1.23

  • AGM Date

    23-Jul-2025

  • EPS

    0.01

  • P/E Ratio

    82.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    32.69

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    39.86

  • BV (₹)

    1.60

  • Sales( ₹ in Cr.)

    22.96

  • NP (in Cr.)

    0.28

  • NP Var(%)

    -55.0

  • Div%

    0.0

  • CPS (₹)

    0.00

  • EPS (₹)

    0.00

  • Traded Value (₹ in Lakhs)

    32.69

  • 52 Week High

    1.29

  • 52 Week Low

    0.80

  • Price BSE

    1.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    32.69

  • P/C Ratio

    142.90

  • P/E Ratio

    143.20

  • Price Vs.BV

    0.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 20.28 62.45 72.64 17.21 2.47 5.87
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 20.28 62.45 72.64 17.21 2.47 5.87
Other Income 1.06 0.56 0.05 0.00 0.00 0.00
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 21.34 63.01 72.69 17.21 2.47 5.87
EXPENDITURE :            
Raw Materials 20.03 59.63 68.84 16.33 1.58 3.36
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.18 0.22 0.25 0.08 0.06 0.09
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.30 0.35
Selling and Administration Expenses 0.26 0.45 0.11 0.09 0.30 0.28
Miscellaneous Expenses 0.00 0.00 0.00 0.28 0.00 0.00
Employee Benefit Expenses 0.18 0.22 0.25 0.08 0.06 0.09
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 20.48 60.31 69.20 16.78 2.24 4.08
Operating Profit 0.86 2.71 3.50 0.43 0.24 1.79
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit 0.86 2.71 3.50 0.43 0.24 1.79
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax 0.86 2.71 3.50 0.43 0.24 1.79
Current Tax 0.23 0.68 0.97 0.11 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.62 2.04 2.53 0.32 0.24 1.79
Extraordinary Items 0.00 0.00 0.00 -0.21 0.00 0.00
Adjusted Net Profit 0.62 2.04 2.53 0.53 0.24 1.79
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 17.06 15.02 12.50 12.18 11.94 10.15
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 17.68 17.06 15.02 12.50 12.18 11.94
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.02 0.05 0.13 0.16 0.12 0.90
Earnings Per Share(Adj)-Unit Curr 0.02 0.05 0.07 0.01 0.01 0.05
Book Value 1.58 1.56 3.03 29.00 28.84 28.72
Book Value(Adj)-Unit Curr 1.58 1.56 1.52 1.45 1.44 1.44

Shareholding Pattern

  • Public Share Holding

    100.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,664,940 1.42 5,664,940 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,664,940 1.42 5,664,940 1
2] Non Institution
Bodies Corporate 858,611 0.22 858,611 31
Clearing Members 1 0.00 1 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,965,944 1.75 6,965,944 310
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 5,188,524 1.30 5,188,524 280
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 60,566,697 15.19 60,566,697 126
Individuals holding nominal share capital up to Rs. 1 lakh 319,306,588 80.10 318,613,588 191,477
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 392,959,060 98.58 392,266,060 192,234
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 398,624,000 100.00 397,931,000 192,235

Company Background

Shree Ganesh Biotech India LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Shree Ganesh Biotech India Ltd
  • BSE Code : 41344.0
  • ISIN : INE051N01026
  • Incorporation Year

    1982

  • Registered Office

    6 Flr Premises-602 Mahavir Apt
    2 Aushutosh Mukherjee Road, Kolkata,
    West Bengal-700020

  • Telephone

  • FAX

  • Chairman

    Aman Patel

  • Managing Director

  • Company Secretary

    Namita Acharya

  • Auditor

    Bipin & co

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    Niche Technologies Pvt Ltd
    D-511 Bagree Market,
    5th Floor,71 B R B Basu Road
    Mumbai - Kolkata - 700001

Shree Ganesh Biotech India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shree Ganesh Bio 0.82 21.33 20.28 82.00 1.36
Abbott India 34,745.50 6,684.73 6,409.15 52.20 44.95
Astrazeneca Phar 8,953.35 1,330.33 1,295.53 193.38 33.26
P & G Health Ltd 5,920.55 1,166.89 1,151.26 39.13 39.76
Glaxosmi. Pharma 3,130.55 3,866.05 3,723.49 57.71 58.72
Cipla 1,473.35 20,029.57 19,044.85 23.08 21.40
Amrutanjan Healt 692.60 437.58 421.23 39.40 20.84
Fermenta Biotec. 379.25 442.21 430.53 16.51 17.61
Guj. Themis Bio. 372.55 174.19 169.82 83.16 44.82
Bliss GVS Pharma 156.90 703.42 667.20 23.99 9.16
Ambalal Sarabhai 34.60 19.33 4.04 32.04 2.10